WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004004664) METHODS FOR TREATING OR PREVENTING ISCHEMIC INJURY
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/004664    International Application No.:    PCT/US2003/021828
Publication Date: 15.01.2004 International Filing Date: 08.07.2003
Chapter 2 Demand Filed:    10.02.2004    
IPC:
A61K 38/18 (2006.01), A61K 38/26 (2006.01)
Applicants: DUKE UNIVERSITY [US/US]; Erwin Road, Durham, NC 27710 (US) (For All Designated States Except US).
STAMLER, Jonathan, S. [US/US]; (US) (For US Only)
Inventors: STAMLER, Jonathan, S.; (US)
Agent: ELRIFI, Ivor, R.; Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., 666 Third Avenue, New York, NY 10017 (US)
Priority Data:
10/192,448 10.07.2002 US
Title (EN) METHODS FOR TREATING OR PREVENTING ISCHEMIC INJURY
(FR) PROCEDES DE TRAITEMENT OU PREVENTION DES LESIONS ISCHEMIQUES
Abstract: front page image
(EN)A therapeutic or prophylactic treatment method of myocardial ischemia, such as due to myocardial infarction, by administering erythropoietin, alone or in combination with other drugs, to a patient suffering from or at risk of cardiac injury, such as myocardial ischemia. The erythropoietin is administered in a concentration such that the subject's hematocrit level or production of red blood cells is not significantly affected.
(FR)L'invention porte sur une méthode de traitement thérapeutique ou prophylactique des ischémies du myocarde dont celles dues à des infarctus, par administration d'érythropoïétine, seule ou combinée à d'autres médicaments, à des patients souffrant d'une lésion cardiaque telle qu'une ischémie du myocarde ou en présentant le risque. L'érythropoïétine s'administre à une concentration telle qu'elle n'affecte pas sensiblement le niveau des hématocrites ou la production de globules rouges.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)